Compulsory licensing is a provision under TRIPS that allows a government to permit the production of a patented product without the consent of the patent owner, under certain conditions. This measure can be crucial for cancer patients in countries that cannot afford expensive patented drugs. Compulsory licenses can facilitate the production of generic drugs, making cancer treatments more accessible and affordable.
